Human umbilical cord mesenchymal stem cell therapy (Kunming Medical University)

N/A

Report date: 2023/01/12 15:28:34

Base Information

Drug NameHuman umbilical cord mesenchymal stem cell therapy (Kunming Medical University)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesKunming Medical University
China Registration ClassN/A

Develop Information

Active CompaniesKunming Medical University
Inactive CompaniesN/A
Active IndicationsDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A